Summit Securities Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-32,949
Closed -$3.27M 565
2019
Q3
$3.27M Buy
+32,949
New +$3.13M 0.29% 61
2017
Q2
Sell
-4,557
Closed -$567K 421
2017
Q1
$567K Sell
4,557
-8,271
-64% -$990K 0.16% 119
2016
Q4
$1.49M Buy
+12,828
New +$1.43M 0.32% 66
2016
Q3
Sell
-11,989
Closed -$1.18M 331
2016
Q2
$1.18M Buy
+11,989
New +$1.24M 0.63% 35

Other funds holding CELG

Summit Securities Group's CELG Position: Q4 2019 in Review

Summit Securities Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 32,949 shares — an estimated $3.27M sold.

Summit Securities Group first reported a position in CELG in Q2 2016 and held it in 4 quarters. The position peaked at $3.27M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Summit Securities Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Summit Securities Group sold 32,949 Celgene Corp shares in Q4 2019, an estimated $3.27M.
  • Summit Securities Group first reported a position in Celgene Corp in Q2 2016 and held it in 4 quarters.
  • Summit Securities Group's Celgene Corp position peaked at $3.27M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Summit Securities Group's 13F filing for Q4 2019, filed 13 Jan 2020.